An application made for this job — a tailored resume and cover letter that speak straight to the posting.
Eisai Inc. in Nutley, NJ, is seeking a Director of Omnichannel Excellence, Scientific Education, Experience & Personalization to architect and drive the omnichannel strategy for Medical Affairs.
The role focuses on scientific education, engagement solutions, and personalized stakeholder experiences across channels, analytics, and technology. The position requires 10+ years in pharmaceutical or related sectors, extensive omnichannel and MSL engagement experience, and strong cross-functional
At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides to patients, their families, and caregivers is Eisai’s human health care (hhc) mission. We’re a growing pharmaceutical company that is breaking through in neurology and oncology, with a strong emphasis on research and development. Our history includes the development of many innovative medicines, notably the discovery of the world's most widely-used treatment for Alzheimer’s disease. As we continue to expand, we are seeking highly-motivated individuals who want to work in a fast-paced environment and make a difference.
The Director, Omnichannel Excellence, Scientific Education, Experience & Personalization serves as the strategic architect and subject matter expert responsible for advancing Medical Affairs omnichannel strategy and integration in pursuit of scientific education and exchange, ensuring omnichannel approaches enhance scientific exchange quality, stakeholder education and evidence communication. This role identifies unmet stakeholder needs and designs, champions, integrates, deploys, and measures innovative scientific education and engagement solutions that improve customer experience and educational outcomes. The Director develops a future-ready roadmap that aligns scientific strategy, field engagement, content, channels, analytics, technology, and emerging capabilities into coordinated, compliant, and personalized stakeholder experiences.
This role is hybrid in Nutley, NJ requiring working in‑office Tuesday, Wednesday and Thursday every week.
Eisai Salary Transparency Language: The annual base salary range for the Director, Omnichannel Excellence, Scientific Education and Evidence Communication is from :$193,600-$254,100 Under current guidelines, this position is eligible to participate in : Eisai Inc. Annual Incentive Plan & Eisai Inc. Long Term Incentive Plan. Final pay determinations will depend on various factors including but not limited to experience level, education, knowledge, and skills. Employees are eligible to participate in Company employee benefit programs. For additional information on Company employee benefits programs, visit https://careers.eisai.com/us/en/compensation-and-benefits.
Eisai Inc. participates in E-Verify. E-Verify is an Internet based system operated by the Department of Homeland Security in partnership with the Social Security Administration that allows participating employers to electronically verify the employment eligibility of all new hires in the United States.
Eisai is an equal opportunity employer and as such, is committed in policy and in practice to recruit, hire, train, and promote in all job qualifications without regard to race, color, religion, gender, age, national origin, citizenship status, marital status, sexual orientation, gender identity, disability or veteran status. Similarly, considering the need for reasonable accommodations, Eisai prohibits discrimination against persons because of disability, including disabled veterans.
All data that is entered should be in the correct case, please refrain from using all caps. For a better user experience, we recommend using the latest version of Chrome.
As the U.S. pharmaceutical subsidiary of Tokyo‑based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia‑related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at www.eisai.com/US and follow us on Twitter and LinkedIn.